U.S. RESEARCH ROUNDUP-Akero Therapeutics, Coca-Cola, Mastec

Quaker Chemical

28/01/2025 06:26

Jan 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed
companies, including Akero Therapeutics, Coca-Cola, and Mastec on Tuesday.

  HIGHLIGHTS 
           
                 * Akero Therapeutics Inc  AKRO.O : Canaccord Genuity raises target price to $73
 from $56
 
                 * AT&T Inc  T.N : RBC raises target price to $27 from $26
 
                 * Coca-Cola Co  KO.N : JP Morgan cuts target price to $70 from $75
 
                 * Mastec Inc  MTZ.N : JP Morgan raises target price to $172 from $154
 
                 * Trico Bancshares  TCBK.O : Stephens cuts target price to $53 from $55
 
                
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in
alphabetical order.   
   
                 * Akero Therapeutics Inc  AKRO.O : Canaccord Genuity raises target price to $73 from $56
 
                 * Akero Therapeutics Inc  AKRO.O : H.C. Wainwright raises target price to $72 from $50
 
                 * Akero Therapeutics Inc  AKRO.O : JP Morgan raises target price to $73 from $49
 
                 * Albemarle  ALB.N : RBC cuts target price to $119 from $133
 
                 * AT&T Inc  T.N : RBC raises target price to $27 from $26
 
                 * AT&T Inc  T.N : Scotiabank raises target price to $26 from $24
 
                 * Avery Dennison Corp  AVY.N : Raymond James cuts target price to $218 from $235
 
                 * Banner Corp  BANR.O : Stephens raises target price to $83 from $82
 
                 * Centuri Holdings Inc  CTRI.N : JP Morgan raises target price to $19 from $17
 
                 * Coca-Cola Co  KO.N : JP Morgan cuts target price to $70 from $75
 
                 * Corteva  CTVA.N : RBC cuts target price to $72 from $73
 
                 * Danaher Corp  DHR.N : RBC cuts target price to $299 from $308
 
                 * Dupont  DD.N : RBC cuts target price to $101 from $104
 
                 * First Financial Bankshares Inc  FFIN.O : Stephens cuts target price to $40 from $44
 
                 * FMC Corp  FMC.N : RBC cuts target price to $78 from $81
 
                 * Forestar Group Inc  FOR.N : JP Morgan cuts target price to $30 from $37
 
                 * Mastec Inc  MTZ.N : JP Morgan raises target price to $172 from $154
 
                 * Mosaic Co  MOS.N : CIBC raises target price to $32 from $30
 
                 * National Bank Holdings Corp  NBHC.N : Stephens cuts target price to $48 from $50
 
                 * Pacific Premier Bancorp Inc  PPBI.O : Stephens cuts target price to $28 from $29
 
                 * Primoris Services Corp  PRIM.N : JP Morgan raises target price to $88 from $77
 
                 * Quaker Houghton  KWR.N : RBC cuts target price to $172 from $180
 
                 * Quanta Services Inc  PWR.N : JP Morgan raises target price to $323 from $297
 
                 * Servisfirst Bancshares Inc  SFBS.N : Piper Sandler raises target price to $96 from $95
 
                 * Silgan Holdings Inc  SLGN.N : Raymond James raises target price to $62 from $60
 
                 * Thermo Fisher Scientific Inc  TMO.N : RBC cuts target price to $689 from $692
 
                 * Trico Bancshares  TCBK.O : Stephens cuts target price to $53 from $55
 
                 * Triumph Financial Inc  TFIN.O : Stephens cuts target price to $85 from $109
 
                 * Union Pacific Corp  UNP.N : Stephens raises target price to $280 from $264
 
                 * Verizon  VZ.N : Raymond James cuts target price to $45 from $48
 
                 * Victoria'S Secret & Co  VSCO.N : Barclays raises target price to $53 from $51
 
                 * Victoria'S Secret & Co  VSCO.N : Barclays raises to overweight from equal weight
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))